Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics up on funding to advance cancer trial

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
8.8% to A$0.062; set to gain most since April 19, if current
trends hold
    ** Drug developer completes A$4.27 million ($2.83 million)
capital raise
    ** Co says funds will be used for the ongoing Phase 2 ACCENT
trial in pancreatic cancer 
    ** Adds, ongoing Phase 2a ACCENT trial in advanced
pancreatic cancer patients is progressing to plan
    ** Stock hits highest level since May 9
    ** Stock has fallen 26.7% this year, as of last close

($1 = 1.5063 Australian dollars)

 (Reporting by Rajasik Mukherjee in Bengaluru)
 ((Rajasik.Mukherjee@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news